Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdel-Hamid, 2009, Theory of mind in schizophrenia: The role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions, Psychiatr. Res., 165, 19, 10.1016/j.psychres.2007.10.021
American Psychiatric Association, 2000, DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders
Bell, 1994, Five-component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale, Psychiatry Res., 52, 295, 10.1016/0165-1781(94)90075-2
Blanchard, 2011, Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia, Schizophr. Bull., 37, 291, 10.1093/schbul/sbq104
Bunk, 1999, Symptom dimensions in the course of child-onset schizophrenia, Eur. Child Adolesc. Psychiatry, 8, I/29, 10.1007/PL00010688
Citrome, 2011, Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis, Schizophr. Res., 131, 75, 10.1016/j.schres.2011.05.018
Cohen, 2008, Computerized measurement of negative symptoms in schizophrenia, J. Psychiatr. Res., 42, 827, 10.1016/j.jpsychires.2007.08.008
Dickinson, 2011, Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls, Schizophr. Bull., 37, 1157, 10.1093/schbul/sbq018
Dollfus, 1995, Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase, Eur. Psychiatry, 10, 97, 10.1016/0924-9338(96)80320-8
Drake, 2003, The evolution of symptoms in the early course of non-affective psychosis, Schizophr. Res., 63, 171, 10.1016/S0920-9964(02)00334-1
Dudek, P.T., 2005. An Examination of the Factor Structure of the SCI-PANSS. Unpublished manuscript, Philadelphia.
Egan, 2001, Relative risk for cognitive impairments in siblings of patients with schizophrenia, Biol. Psychiatry, 50, 98, 10.1016/S0006-3223(01)01133-7
Emsley, 2003, The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis, Schizophr. Res., 61, 47, 10.1016/S0920-9964(02)00302-X
Flora, 2004, An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data, Psychol. Methods, 9, 466, 10.1037/1082-989X.9.4.466
Fredrikson, 1997, PANSS symptom factors in schizophrenia, Schizophr. Res., 24, 15, 10.1016/S0920-9964(97)82039-7
Fresán, 2005, A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenia patients, Schizophr. Res., 72, 123, 10.1016/j.schres.2004.03.021
Higashima, 1998, P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia, Biol. Psychiatry, 44, 115, 10.1016/S0006-3223(97)00359-4
Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261
Kline, 2010
Lançon, 2000, Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS), Schizophr. Res., 42, 231, 10.1016/S0920-9964(99)00129-2
Lee, 2003, The Five Symptom Dimensions and Depression in Schizophrenia, Psychopathology, 36, 226, 10.1159/000073447
Lehoux, 2009, The Five-Factor Structure of the PANSS: A Critical Review of its Consistency Across Studies, Clin. Schizophr. Relat. Psychoses, 3, 103, 10.3371/CSRP.3.2.5
Lépine, 1991, Dimensions positives et négatives dans les schizophrénies, Les Cahiers de Prisme, 1, 23
Levine, 2007, Revisiting the 5 Dimensions of the Positive and Negative Syndrome Scale, J. Clin. Psychopharmacol., 27, 431, 10.1097/jcp/.0b013e31814cfabd
Lindenmayer, 1995, Psychopathology of schizophrenia: initial validation of a 5-factor model, Psychopathology, 28, 22, 10.1159/000284896
Lindenmayer, 1995, Five factor model of schizophrenia: replication across samples, Schizophr. Res., 14, 229, 10.1016/0920-9964(94)00041-6
Lindstrom, 1993, Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia, Nord. J. Psychiatry, 47, 257, 10.3109/08039489309103335
Llorca, 2011, Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling, Eur. Psychiatry
Lykouras, 2000, Five-factor model of schizophrenic psychopathology: how valid is it?, Eur. Arch. Psychiatry Clin. Neurosci., 250, 93, 10.1007/s004060070041
Marder, 1997, The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials, J. Clin. Psychiatry, 58, 538, 10.4088/JCP.v58n1205
Mass, 2000, Psychopathological Syndromes of Schizophrenia: Evaluation of the Dimensional Structure of the Positive and Negative Syndrome Scale, Schizophr. Bull., 26, 167, 10.1093/oxfordjournals.schbul.a033437
Monteiro, 2008, Insight, cognitive dysfunction and symptomatology in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 258, 402, 10.1007/s00406-008-0809-8
Muthén, 1998
Ohi, 2011, The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex, Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 1309, 10.1016/j.pnpbp.2011.04.008
Serretti, 2004, Dimensions of major psychoses: a confirmatory factor analysis of six competing models, Psychiatry Res., 127, 101, 10.1016/j.psychres.2003.07.005
Van den Oord, 2006, Factor structure and external validity of the PANSS revisited, Schizophr. Res., 82
van der Gaag, 2006, The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions, Schizophr. Res., 85, 273, 10.1016/j.schres.2006.04.001
van der Gaag, 2006, The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model, Schizophr. Res., 85, 280, 10.1016/j.schres.2006.03.021
von Knorring, 1995, Principal components and further possibilities with the PANSS, Acta Psychiatr. Scand., 91, 5, 10.1111/j.1600-0447.1995.tb05937.x
White, 1997, Empirical assessment of the factorial structure of clinical symptoms in schizophrenia, Psychopharmacology, 30, 263